RA
ELV icon

Ruggaard & Associates’s Elevance Health ELV Stock Holding History

Ruggaard & Associates’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$636K Hold
1,644
– – 0.23% 63
2026
Q1 		$481K Hold
1,644
– – 0.19% 68
2025
Q4 		$576K Hold
1,644
– – 0.23% 60
2025
Q3 		$531K Hold
1,644
– – 0.2% 63
2025
Q2 		$639K Sell
1,644
-6
-0.4% -$2.41K 0.26% 52
2025
Q1 		$718K Buy
1,650
+41
+3% +$16.5K 0.31% 42
2024
Q4 		$594K Hold
1,609
– – 0.26% 50
2024
Q3 		$837K Buy
+1,609
New +$860K 0.36% 37

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ruggaard & Associates's ELV Position: Q2 2026 in Review

Ruggaard & Associates held its Elevance Health (ELV) position steady in Q2 2026 at 1,644 shares worth $636K. The position accounts for 0.23% of the portfolio, ranked #63.

Ruggaard & Associates first reported a position in ELV in Q3 2024 and has held it in 8 quarters since. The position peaked at $837K in Q3 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Ruggaard & Associates held 1,644 shares of Elevance Health worth $636K as of Q2 2026.
  • Ruggaard & Associates left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.23% of Ruggaard & Associates's portfolio in Q2 2026, its #63 holding.
  • Ruggaard & Associates first reported a position in Elevance Health in Q3 2024 and has held it in 8 quarters since.
  • Ruggaard & Associates's Elevance Health position peaked at $837K in Q3 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Ruggaard & Associates's 13F filing for Q2 2026, filed 17 Aug 2026.